#USA #Tampa #PainTEQ #Mike Sherman #SI Joint

PainTEQ Welcomes Mike Sherman to Its Board of Directors

In a significant development for the medical device industry, PainTEQ—a leading company in innovative and minimally invasive solutions for sacroiliac (SI) joint dysfunction—has proudly announced the appointment of Mike Sherman to its Board of Directors as of September 24, 2025. This strategic move aims to leverage Sherman's extensive expertise and leadership in orthopedic innovation to further enhance the company's growth trajectory.

Who is Mike Sherman?

Mike Sherman brings with him over 30 years of leadership experience, specifically within the realm of medical device innovation. His former roles include creating and leading the Technology Development group at Medtronic's Spine division, where he was responsible for pioneering novel product solutions and spearheading business development activities related to spinal care. His vast contributions to the field of orthopedics are underscored by his position as a Partner at MB Venture Partners, where he managed investments in early-stage musculoskeletal companies for nearly a decade.

In addition to his impressive career at Medtronic, Sherman founded MB Innovations in 2011, where he has served as Executive Chairman and later transitioned to President and CEO in 2017. His expertise is further reinforced by being an inventor on over 130 U.S. patents covering spinal implants, surgical instruments, and minimally invasive techniques.

Comments from Leadership

Shanth Thiyagalingam, CEO of PainTEQ, emphasized Sherman's wealth of hands-on experience in orthopedic innovation, expressing confidence that his knowledge will play an invaluable role as PainTEQ continues to accelerate the adoption of its flagship product, the LinQ® SI Joint Stabilization System. Thiyagalingam stated, Mike is a skilled architect and an avid disciple of the AO principles. He brings deep, hands–on expertise in orthopedic innovation, product development, and strategic partnerships.

Sherman himself expressed enthusiasm about joining PainTEQ, stating, I'm honored to be part of PainTEQ's Board. PainTEQ is setting a new standard for treating SI joint dysfunction with a patient-focused, minimally invasive approach. I look forward to partnering with Shanth and the Board to help guide the company's strategy and deliver meaningful solutions to patients worldwide.

A Commitment to Innovation

Dr. Timothy Deer, Co–Chair of the American Society of Pain and Neuroscience (ASPN), also commented on this crucial appointment, noting that Sherman's track record in innovation aligns perfectly with PainTEQ's mission. His track record in innovation is exactly what's needed to ensure that new technologies like LinQ® reach the patients who need them most, he remarked.

PainTEQ, founded in 2013 and based in Tampa, Florida, focuses on developing interventional pain management solutions aimed at alleviating back pain and treating SI joint dysfunction. To date, the company’s proprietary SI joint implant system has been utilized in over 14,000 procedures, providing patients with minimally invasive options for chronic pain relief.

In conclusion, Mike Sherman’s appointment to PainTEQ’s Board of Directors signifies a pivotal step in the company's quest to expand its product portfolio and accelerate growth. As the medical device industry continues to evolve, PainTEQ remains committed to providing innovative and effective solutions for patients suffering from SI joint dysfunction, driven by expert leadership and a passion for improving patient outcomes.